-transparent.png){kind=logo}
It is shown that daily oral administration of 5--10 mg of an antidiabetic biguanide-phenformin (phenethyl-biguanide) for 2.5--5 months suppressed DMBA-induced mammary tumour development in rats considerably. Phenformin-treated rats revealed-a tendency towards a decrease in blood insulin level (radioimmunoassay). The obtained data are regarded as additional evidence for the proposed existence of the same metabolic background of diseases of compensation, i.e. adult-onset diabetes, artherosclerosis and cancer, and suggest studies on possible antitumour effect of phenformin in man.
Related Publications
V M Dilman, and
L M Berstein, and
M A Zabezhinski, and
V A Alexandrov, and
J F Bobrov, and
G B Pliss
January 1991,
Nutrition and cancer,
V M Dilman, and
L M Berstein, and
M A Zabezhinski, and
V A Alexandrov, and
J F Bobrov, and
G B Pliss
January 1997,
British journal of cancer,
V M Dilman, and
L M Berstein, and
M A Zabezhinski, and
V A Alexandrov, and
J F Bobrov, and
G B Pliss
January 1981,
Cancer detection and prevention,
V M Dilman, and
L M Berstein, and
M A Zabezhinski, and
V A Alexandrov, and
J F Bobrov, and
G B Pliss
November 1981,
International journal of cancer,
V M Dilman, and
L M Berstein, and
M A Zabezhinski, and
V A Alexandrov, and
J F Bobrov, and
G B Pliss
October 1983,
International journal of cancer,
V M Dilman, and
L M Berstein, and
M A Zabezhinski, and
V A Alexandrov, and
J F Bobrov, and
G B Pliss
July 1998,
Breast cancer research and treatment,
V M Dilman, and
L M Berstein, and
M A Zabezhinski, and
V A Alexandrov, and
J F Bobrov, and
G B Pliss
May 1989,
The Journal of nutrition,
V M Dilman, and
L M Berstein, and
M A Zabezhinski, and
V A Alexandrov, and
J F Bobrov, and
G B Pliss
January 1982,
Neoplasma,
V M Dilman, and
L M Berstein, and
M A Zabezhinski, and
V A Alexandrov, and
J F Bobrov, and
G B Pliss
June 2012,
Carcinogenesis,
V M Dilman, and
L M Berstein, and
M A Zabezhinski, and
V A Alexandrov, and
J F Bobrov, and
G B Pliss
January 1985,
Oncology,
